The inflammatory bowel disease market is rapidly growing, driven by unmet patient needs despite existing therapies. Major pharma acquisitions highlight strong demand for innovative treatments. Abivax’s...
The company Pfizer has followed in the vein of other big pharma companies. The American giant has entered the medical cannabis market in a $6.7 billion...